Genetron Limited (GTH)
4.03
0.01 (0.25%)
At close: Mar 28, 2024, 8:00 PM
0.25% (1D)
| Bid | n/a |
| Market Cap | 127.29M |
| Revenue (ttm) | 650.71M |
| Net Income (ttm) | -801.96M |
| EPS (ttm) | -3.62 |
| PE Ratio (ttm) | -1.111878453038674 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 412,603 |
| Avg. Volume (20D) | 51,864 |
| Open | 4.02 |
| Previous Close | 4.02 |
| Day's Range | 4.02 - 4.05 |
| 52-Week Range | 2.08 - 4.05 |
| Beta | 0.50 |
About GTH
Genetron Holdings Limited, a precision oncology company, engages in the cancer molecular profiling, and harnessing technologies in molecular biology and data science for cancer treatment. The company offers diagnosis and monitoring services, and early screening services through laboratory developed tests services. It also provides in-vitro diagnostic products, including 8-gene lung cancer assay, an IVD assay product to detect lung cancer; Genetro...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date Jun 15, 2020
Employees 993
Stock Exchange NASDAQ
Ticker Symbol GTH
Website https://www.genetronhealth.com